Team – Dr. med. T. Tessmann #NewDoctor #NewPainSpecialist
From June, Dr. Tobias Tessmann will join ISSZ. He already worked as a resident in anesthesiology at Spital Lachen from 2019-2021 together with Dr. J. Ludwigs and was also the first pain fellow to receive specialized pain management training from Dr. Ludwigs.
The friendship that developed during this time, as well as the shared interest in interventional pain medicine, remained strong. After completing his specialist training in anesthesiology at the University Hospital Zurich, the University Children’s Hospital Zurich, and with the Swiss Air-Rescue (REGA), he will now actively support the Institute for Interventional Pain Medicine SZ AG with his own consultations.
We are very excited for his start and his contribution to the joint care of your patients. Welcome to the #Team, Tobias!
Subscribe to Newsletter
We’d be happy to share more about us and our services in the next newsletter and on www.issz.ch.
Current Affairs
Further News & Publications
Certification as an SSIPM Training Centre Pain Clinic B
We recently announced that we would apply for certification as an SSIPM training centre “Pain Clinic B”. We are now very pleased to have received
Cooperation with the Institute for Interventional Pain Medicine Zurich AG (IISZ)
Similar to the long-standing, close friendship and professional relationship between Jan Ludwigs and Daniel Friis, the connection between the ISSZ and the Institute for Interventional
Suzetrigin: A Novel Pain Medication in Switzerland
Suzetrigin (brand name: Journavx™) is an innovative, non-opioid analgesic that was approved in January 2025 by the U.S. FDA for the treatment of moderate to
Pulsed Radiofrequency Treatment (pRF)
Die gepulste Radiofrequenz-Behandlung (pRF) stellt eine minimalinvasive, nicht-destruktive Methode zur Behandlung
chronischer Schmerzen dar. Im Gegensatz zur thermischen Radiofrequenzablation, die durch Hitzeeinwirkung Nerven
1 year of Interventional Pain Medicine SZ AG – Less pain, more quality of life
On 3 May 2025, we celebrated the one-year anniversary of the Institute for Interventional Pain Medicine SZ AG – a significant milestone on our journey
Neuromodulation: Innovative Approaches to Chronic Pain
The term neuromodulation encompasses a variety of established therapeutic methods, including not only spinal epidural neurostimulation (Spinal Cord Stimulation – SCS), which is often used
Team – Dr. med. T. Tessmann #NewDoctor #NewPainSpecialist
From June, Dr. Tobias Tessmann will join ISSZ. He already worked as a resident in anesthesiology at Spital Lachen from 2019-2021 together with Dr. J.
Certification as an SSIPM Training Centre Pain Clinic B
We recently announced that we would apply for certification as an SSIPM training centre “Pain Clinic B”. We are now very pleased to have received
Cooperation with the Institute for Interventional Pain Medicine Zurich AG (IISZ)
Similar to the long-standing, close friendship and professional relationship between Jan Ludwigs and Daniel Friis, the connection between the ISSZ and the Institute for Interventional
Suzetrigin: A Novel Pain Medication in Switzerland
Suzetrigin (brand name: Journavx™) is an innovative, non-opioid analgesic that was approved in January 2025 by the U.S. FDA for the treatment of moderate to
Pulsed Radiofrequency Treatment (pRF)
Die gepulste Radiofrequenz-Behandlung (pRF) stellt eine minimalinvasive, nicht-destruktive Methode zur Behandlung
chronischer Schmerzen dar. Im Gegensatz zur thermischen Radiofrequenzablation, die durch Hitzeeinwirkung Nerven
1 year of Interventional Pain Medicine SZ AG – Less pain, more quality of life
On 3 May 2025, we celebrated the one-year anniversary of the Institute for Interventional Pain Medicine SZ AG – a significant milestone on our journey